XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows (used in) provided by operating activities:    
Net loss [1] $ (76,887,000) $ (142,966,000)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization [1] 28,591,000 31,416,000
Write-off of deferred financing costs [1] 2,748,000 0
Amortization of deferred financing costs, debt issuance costs, and debt warrant discounts [1] 25,666,000 6,388,000
Paid-in-kind interest [1] 15,464,000 0
Allowance for credit losses [1] (362,000) 1,985,000
Foreign currency losses [1] 571,000 4,274,000
Deferred income taxes [1] 382,000 5,083,000
(Gain) loss on asset disposals [1] (4,296,000) 17,000
Goodwill impairment charges 0 55,837,000
Non-cash compensation costs [1] 571,000 5,576,000
Other, net [1] (3,469,000) (3,629,000)
Changes in operating assets and liabilities:    
Accounts receivable [1] (31,313,000) (14,817,000)
Inventory [1] (3,076,000) (334,000)
Prepaid expenses and other current assets [1] (7,048,000) 3,700,000
Accounts payable [1] (6,038,000) 6,012,000
Other accrued liabilities [1] 5,911,000 5,321,000
Income taxes [1] 6,220,000 276,000
Net cash used in operating activities [1] (46,365,000) (35,861,000)
Cash flows used in investing activities:    
Capital expenditures [1] (21,002,000) (12,376,000)
Proceeds from disposal of assets [1] 7,165,000 154,000
Net cash used in investing activities [1] (13,837,000) (12,222,000)
Cash flows (used in) provided by financing activities:    
Borrowings under ABL Credit Facility (Eclipse) [1] 106,531,000 0
Payments under ABL Credit Facility (Eclipse) [1] (11,715,000) 0
Borrowings under Corre Delayed Draw Term Loans (ABL Credit Facility (Corre)) [1] 35,000,000 0
Borrowings under ABL Facility (Citibank), net [1] 0 46,300,000
Borrowings under ABL Facility (Citibank), gross [1] 10,300,000 124,700,000
Payments under ABL Facility (Citibank), gross [1] (72,300,000) (125,900,000)
Payments for debt issuance costs [1] (13,609,000) (2,899,000)
Issuance of common stock [1] 9,696,000 0
Taxes paid related to net share settlement of share-based awards [1] 0 (102,000)
Other [1] (615,000) (356,000)
Net cash provided by financing activities [1] 63,288,000 41,743,000
Effect of exchange rate changes on cash and cash equivalents [1] (1,373,000) (1,274,000)
Net increase (decrease) in cash and cash equivalents [1] 1,713,000 (7,614,000)
Cash and cash equivalents at beginning of period [1] 65,315,000 24,586,000
Cash and cash equivalents at end of period [1] $ 67,028,000 $ 16,972,000
[1] Condensed consolidated statements of cash flows include discontinued operations.
September 30, 2022September 30, 2021
Cash and cash equivalents from continuing operations$56,387 $12,009 
Cash and cash equivalents from discontinued operations10,641 4,963 
Total$67,028 $16,972